Kaya Holdings (OTCQB:KAYS) Unveils “The Scared Mushroom(TM)”, the First U.S.-Based Psilocybin Center to be Operated by a U.S. Public Company
November 7, 2023
Ryan Allway November 7th, 2023 News, Psychedelics, Top News, Top Story FT. LAUDERDALE, FL / ACCESSWIRE / November 7, 2023 / Kaya Holdings, Inc., (“KAYS” or the “Company”) (OTCQB:KAYS) has shared the company’s progress to open “The Sacred Mushroom™” Psilocybin Facilitation Center in Portland, Oregon and invites interested parties to... Read more
Kaya Holdings (OTCQB:KAYS) Closes Additional Round of Non-Dilutive Bridge Financing Targeted to Complete The Sacred Mushroom™ Psilocybin Treatment Center
October 18, 2023
Ryan Allway October 18th, 2023 News, Psychedelics, Top News, Top Story KAYS’ Oregon Based Psilocybin Treatment Center is on track to be the first of its kind operated by a U.S. Public Company FT. LAUDERDALE, FL / ACCESSWIRE / October 18, 2023 / Kaya Holdings, Inc., (“KAYS” or the “Company”)... Read more
Ryan Allway June 14th, 2023 News, Psychedelics, Top News, Top Story Springfield, Oregon–(Newsfile Corp. – June 14, 2023) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) (“Silo” or “the Company”), a pioneer in psilocybin wellness retreats, is excited to announce its feature this Sunday on a groundbreaking CNN documentary... Read more
Kaya Holdings, Inc.’s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A.
May 24, 2023
Ryan Allway May 24th, 2023 Psychedelics, Top News KAYS’ Fifth Dimension Therapeutics Plans to Open “The Sacred Mushroom™” Psilocybin Centers in Oregon, Marking Entry into the Global Psychedelics Market, which is Forecast to Exceed $8 Billion by 2029. FT. LAUDERDALE, FL / ACCESSWIRE / May 24, 2023 / Kaya Holdings,... Read more
Ryan Allway May 9th, 2023 Psychedelics, Top Story MindBio clinical trial published in Peer Reviewed Paper Biological Psychiatry First of 8 significant publications on LSD-Microdosing from a Phase 1 clinical trial Phase 1 Clinical trial produced outstanding mood responses in healthy participants MindBio is developing a Microdosing treatment protocol... Read more
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression
April 21, 2023
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Public Offering for Clearmind Medicine Inc. (NASDAQ: CMND)
April 10, 2023
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Ryan Allway April 4th, 2023 Psychedelics, Top News Tel Aviv, Israel / Vancouver, Canada, April 04, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today... Read more
Doseology Announces CEO Transition
March 31, 2023
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Silo Wellness Eliminates Another CAD$4,440,000 of Debt from Balance Sheet by Disposing of Subsidiary
March 28, 2023
Ryan Allway March 28th, 2023 News, Psychedelics, Top News Springfield, Oregon–(Newsfile Corp. – March 28, 2023) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A), announces that the Company has entered into a definitive Stock Purchase Agreement dated March 27 2023 (the “Agreement”) with a non-arm’s length entity owned by... Read more
